PBAC July 2020 Meeting Outcomes
Summary of the Pharmaceutical Benefits Advisory Committee July 2020 meeting outcomes.
Alpha-1 Antitrypsin Genotyping MSAC Submission
Lung Foundation Australia submission to the Medical Services Advisory Committee (MSAC) supports the Royal College of Pathologists of Australasia application to list Alpha-1 Antitrypsin (AAT)…
Survey of Lung Foundation Australia Alpha1 Community
Lung Foundation Australia members and supporters with Alpha1 deficiency and clinicians provided their views on the proposed test and its impact through our Survey.
Submission to the Senate Select Committee on COVID-19
Our submission to your inquiry into the Federal Government’s response to the COVID-19 pandemic, is focused on protecting and securing the lung health of all…
Submission: Lung Cancer Screening in Australia
In 2020, Australia must determine the best way to use a national lung cancer screening program to: save Australian lives; develop innovative technologies and solutions…
Submission: Proposed changes to the Mining and Quarrying Safety and Health Regulation 2017
Lung Foundation Australia’s joint submission with Cancer Council Queensland, to the Queensland Government on health surveillance for mineral miners and quarry workers.
National Strategic Action Plan for Lung Conditions: Occupational Dust Diseases
Lung Foundation Australia’s submission for the Dust Diseases Taskforce.
Tip sheet for submitting consumer comments to the PBAC
This tip sheet was written by Lisa Briggs, a Stage IV Lung Cancer Patient and Advocate, whose long experience advocating for life saving drugsto be…
Environmental Justice Australia Vales Point Power Station
A joint position paper with other peak health bodies regarding Vales Point Power Station.
Environmental Justice Australia Yallourn Power Station
A joint position paper with other peak health bodies regarding the Yallourn Power Station.